- Reagents and consumables
- Instruments
- Mass Spectrometry Instruments
- Edman Degradation Sequencers
- Analysis Software
- Protein Sequencing Services
Protein Sequencing Market size was valued at USD 794.8 million in 2022 and is expected to reach USD 962.1 million by 2028, at a significant CAGR of 5.5% from 2023-2029. Due to the increasing focus on target-based drug development activities by biotechnology and pharmaceutical companies and increasing demand for protein biomarkers in the process of drug development. Moreover, the growing application of protein sequencing technique for identifying novel peptides in human antibodies and antigens and advancements in clinical mass spectrometry and analytical techniques are driving the growth of the global protein sequencing market over the forecast timeframe. This report studies global protein sequencing market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global protein sequencing market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global protein sequencing market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increasing focus on target based drug development activities is a key factor drive the global protein sequencing market. Due to the advancements in research, biotechnological and pharmaceutical companies are now focusing on the drug discovery and development based on target. The targeted receptor is made of protein for which we can determine the sequence of amino acids and then we can develop molecule for that particular sequence so that the drug can only bind to that particular site to prevent the adverse effects. Moreover, increasing R&D expenditure of major pharmaceutical and biotechnology companies, decreasing cost of sequencing and increasing number of sequencing service providers are the factors believed to propel the global protein sequencing market over the forecast years.
The key segments covered in the Protein Sequencing Market are technology, components, application, and end-users.
The Protein Sequencing Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Protein Sequencing Market key players Agilent Technologies, Inc. (US), QIAGEN N.V. (Netherlands), Rapid Novor (Canada), Charles River Laboratories (US), Selvita (Poland), SGS S.A. (Switzerland), BGI Group (China), Thermo Fisher Scientific, Inc. (U.S), Bioinformatics Solutions Inc. (Canada), Proteome Factory AG (Germany), Shimadzu Corporation (Japan)